James McNamara, Scientific Founder and CEO of Nuclease Probe Technologies
Nuclease Probe Technologies, one of 21 MedTech startup finalists in the 8th annual M2D2 $200K Challenge, was chosen for their development of a novel diagnostic for accurate and early detection of bloodstream infections (BSI’s).
We spoke with Scientific Founder and CEO, James McNamara, who shared the story of their innovation with us.
Randy Werneth, CEO and President of CardioCorX
Introducing CardioCorX, one of 21 MedTech startups chosen as finalists in the 8th annual M2D2 $200K Challenge. We spoke with CEO and President, Randy Werneth, who shared the story of their innovation.
CardioCorX was chosen for their development of a simple integrative medical approach for patients suffering from atrial fibrillation with or without heart failure.
Daniel Burnett, Evan Luxon, and Eric Kriegstein of Respirix.
Introducing Respirix, one of 21 medtech startups chosen as finalists in the 8th annual M2D2 $200K Challenge. We spoke with CEO Eric Kriegstein who shared the story of their innovation.
Respirix is developing a hardware and software platform to change the paradigm for non-invasively monitoring, and managing, patient health.
21 finalists have been selected from over 150 applicants for the 8th Annual M2D2 $200K Challenge. This year’s participation sets a new record for the competition!
LOWELL, Massachusetts – The University of Massachusetts Medical Device Development Center (M2D2) today announced the finalists in its 8th annual $200K Challenge after reviewing a record-setting 150+ applications. Continue reading
Nuclease Probe Technologies has raised $500,000 from Breakout Labs to Support Development of Rapid Antibiotic Susceptibility Testing for Bloodstream Infections.
With this funding, NPT will commence operations at M2D2 in Lowell. We’re thrilled to welcome the new resident company and look forward to aiding them with the tools and space needed for further development! Continue reading
Marlborough, MA — Hologic, Inc. is the newest sponsor of the Massachusetts Medical Device Development Center (M2D2). M2D2 is a University of Massachusetts Lowell and Medical School-affiliated incubator for early stage startups that runs the annual $200K Challenge international competition to showcase innovative medical device, diagnostic, and biotech companies. Continue reading
The M2D2 Challenge has grown immensely over the last 8 years. With that growth we’ve seen a large increase in applicants—and questions!
The M2D2 $200K Challenge has always drawn entrants from around the world. This year, a Challenge sponsor is giving India-based innovators an extra-generous incentive to participate.
The Deshpande Foundation has announced that they will fund up to three $200K Challenge finalist teams to travel from India to M2D2 from approximately March 10th to April 10th. Continue reading
Venture financing is every entrepreneur’s goal— so every entrepreneur needs a plan to get his or her startup to the venture financing stage. That’s why M2D2 is hosting an informative happy hour: Simplifying Venture Financing: What You Need To Know, after work on Wednesday, January 30. For knowledge-gathering and great networking (plus food and drinks), it’s a don’t-miss event for Boston-area life sciences startups. Continue reading
Great news for cost-conscious medical device innovators: M2D2 is waiving the $50 entry fee for the first ten submissions to our 2019 $200K Challenge! Entries are open now—to get your application started, visit www.m2m2challenge.com.